Literature DB >> 29221805

Skeletal Muscle Regenerative Potential of Human MuStem Cells following Transplantation into Injured Mice Muscle.

Judith Lorant1, Charlotte Saury2, Cindy Schleder1, Florence Robriquet3, Blandine Lieubeau4, Elisa Négroni5, Isabelle Leroux1, Lucie Chabrand6, Sabrina Viau6, Candice Babarit1, Mireille Ledevin1, Laurence Dubreil1, Antoine Hamel7, Armelle Magot8, Chantal Thorin9, Laëtitia Guevel3, Bruno Delorme6, Yann Péréon8, Gillian Butler-Browne5, Vincent Mouly5, Karl Rouger10.   

Abstract

After intra-arterial delivery in the dystrophic dog, allogeneic muscle-derived stem cells, termed MuStem cells, contribute to long-term stabilization of the clinical status and preservation of the muscle regenerative process. However, it remains unknown whether the human counterpart could be identified, considering recent demonstrations of divergent features between species for several somatic stem cells. Here, we report that MuStem cells reside in human skeletal muscle and display a long-term ability to proliferate, allowing generation of a clinically relevant amount of cells. Cultured human MuStem (hMuStem) cells do not express hematopoietic, endothelial, or myo-endothelial cell markers and reproducibly correspond to a population of early myogenic-committed progenitors with a perivascular/mesenchymal phenotypic signature, revealing a blood vessel wall origin. Importantly, they exhibit both myogenesis in vitro and skeletal muscle regeneration after intramuscular delivery into immunodeficient host mice. Together, our findings provide new insights supporting the notion that hMuStem cells could represent an interesting therapeutic candidate for dystrophic patients.
Copyright © 2017 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DMD; MuStem; cell therapy; human adult stem cells; regenerative medicine; skeletal muscle

Mesh:

Year:  2017        PMID: 29221805      PMCID: PMC5835152          DOI: 10.1016/j.ymthe.2017.10.013

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  128 in total

1.  Pax7 distribution in human skeletal muscle biopsies and myogenic tissue cultures.

Authors:  Jens Reimann; Karima Brimah; Rolf Schröder; Anton Wernig; Jonathan R Beauchamp; Terence A Partridge
Journal:  Cell Tissue Res       Date:  2003-11-26       Impact factor: 5.249

2.  Pericytes resident in postnatal skeletal muscle differentiate into muscle fibres and generate satellite cells.

Authors:  A Dellavalle; G Maroli; D Covarello; E Azzoni; A Innocenzi; L Perani; S Antonini; R Sambasivan; S Brunelli; S Tajbakhsh; G Cossu
Journal:  Nat Commun       Date:  2011-10-11       Impact factor: 14.919

3.  Transplanted hematopoietic stem cells demonstrate impaired sarcoglycan expression after engraftment into cardiac and skeletal muscle.

Authors:  Karen A Lapidos; Yiyin E Chen; Judy U Earley; Ahlke Heydemann; Jill M Huber; Marcia Chien; Averil Ma; Elizabeth M McNally
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

4.  Culture and characterization of human bone marrow mesenchymal stem cells.

Authors:  Bruno Delorme; Pierre Charbord
Journal:  Methods Mol Med       Date:  2007

5.  Ex vivo expansion of human circulating myogenic progenitors on cluster-assembled nanostructured TiO2.

Authors:  Marzia Belicchi; Silvia Erratico; Paola Razini; Mirella Meregalli; Alessandra Cattaneo; Emanuela Jacchetti; Andrea Farini; Chiara Villa; Nereo Bresolin; Laura Porretti; Cristina Lenardi; Paolo Milani; Yvan Torrente
Journal:  Biomaterials       Date:  2010-04-15       Impact factor: 12.479

6.  Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo.

Authors:  Christian A J Vosshenrich; Thomas Ranson; Sandrine I Samson; Erwan Corcuff; Francesco Colucci; Eleftheria E Rosmaraki; James P Di Santo
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

7.  Canine X-linked muscular dystrophy: morphologic lesions.

Authors:  B A Valentine; B J Cooper; J F Cummings; A de Lahunta
Journal:  J Neurol Sci       Date:  1990-06       Impact factor: 3.181

Review 8.  Mesoangioblasts--vascular progenitors for extravascular mesodermal tissues.

Authors:  Giulio Cossu; Paolo Bianco
Journal:  Curr Opin Genet Dev       Date:  2003-10       Impact factor: 5.578

9.  Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells.

Authors:  Arianna Dellavalle; Maurilio Sampaolesi; Rossana Tonlorenzi; Enrico Tagliafico; Benedetto Sacchetti; Laura Perani; Anna Innocenzi; Beatriz G Galvez; Graziella Messina; Roberta Morosetti; Sheng Li; Marzia Belicchi; Giuseppe Peretti; Jeffrey S Chamberlain; Woodring E Wright; Yvan Torrente; Stefano Ferrari; Paolo Bianco; Giulio Cossu
Journal:  Nat Cell Biol       Date:  2007-02-11       Impact factor: 28.824

10.  Preclinical studies with umbilical cord mesenchymal stromal cells in different animal models for muscular dystrophy.

Authors:  Eder Zucconi; Natassia Moreira Vieira; Carlos Roberto Bueno; Mariane Secco; Tatiana Jazedje; Marcos Costa Valadares; Miriam Fussae Suzuki; Paolo Bartolini; Mariz Vainzof; Mayana Zatz
Journal:  J Biomed Biotechnol       Date:  2011-07-15
View more
  11 in total

1.  A modified preplate technique for efficient isolation and proliferation of mice muscle-derived stem cells.

Authors:  Zhuqiu Xu; Lu Yu; Haibin Lu; Weifeng Feng; Lulu Chen; Jing Zhou; Xiaonan Yang; Zuoliang Qi
Journal:  Cytotechnology       Date:  2018-11-11       Impact factor: 2.058

2.  Restoration of Functional Full-Length Dystrophin After Intramuscular Transplantation of Foamy Virus-Transduced Myoblasts.

Authors:  Jinhong Meng; Nathan Paul Sweeney; Bruno Doreste; Francesco Muntoni; Myra McClure; Jennifer Morgan
Journal:  Hum Gene Ther       Date:  2020-01-10       Impact factor: 5.695

Review 3.  Human muscle production in vitro from pluripotent stem cells: Basic and clinical applications.

Authors:  Lu Yan; Alejandra Rodríguez-delaRosa; Olivier Pourquié
Journal:  Semin Cell Dev Biol       Date:  2021-04-30       Impact factor: 7.727

Review 4.  Cell therapy to improve regeneration of skeletal muscle injuries.

Authors:  Taimoor H Qazi; Georg N Duda; Melanie J Ort; Carsten Perka; Sven Geissler; Tobias Winkler
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-03-06       Impact factor: 12.910

5.  Combined methods to evaluate human cells in muscle xenografts.

Authors:  Mona Bensalah; Pierre Klein; Ingo Riederer; Soraya Chaouch; Laura Muraine; Wilson Savino; Gillian Sandra Butler-Browne; Capucine Trollet; Vincent Mouly; Anne Bigot; Elisa Negroni
Journal:  PLoS One       Date:  2019-05-02       Impact factor: 3.240

6.  Characterization of traumatized muscle-derived multipotent progenitor cells from low-energy trauma.

Authors:  Marvin Dingle; Stephen D Fernicola; Jaira F de Vasconcellos; Sonia Zicari; Christopher Daniels; John C Dunn; Alexander Dimtchev; Leon J Nesti
Journal:  Stem Cell Res Ther       Date:  2021-01-06       Impact factor: 6.832

Review 7.  Systemic cell therapy for muscular dystrophies : The ultimate transplantable muscle progenitor cell and current challenges for clinical efficacy.

Authors:  Hans van Bokhoven; Derick G Wansink; C Rosanne M Ausems; Baziel G M van Engelen
Journal:  Stem Cell Rev Rep       Date:  2020-12-21       Impact factor: 5.739

8.  Human MuStem cells repress T-cell proliferation and cytotoxicity through both paracrine and contact-dependent pathways.

Authors:  Marine Charrier; Judith Lorant; Farida Djouad; Karl Rouger; Rafael Contreras-Lopez; Gautier Téjédor; Christophe Blanquart; Blandine Lieubeau; Cindy Schleder; Isabelle Leroux; Sophie Deshayes; Jean-François Fonteneau; Candice Babarit; Antoine Hamel; Armelle Magot; Yann Péréon; Sabrina Viau; Bruno Delorme; Patricia Luz-Crawford; Guillaume Lamirault
Journal:  Stem Cell Res Ther       Date:  2022-01-10       Impact factor: 6.832

Review 9.  Current Strategies for the Regeneration of Skeletal Muscle Tissue.

Authors:  Emine Alarcin; Ayca Bal-Öztürk; Hüseyin Avci; Hamed Ghorbanpoor; Fatma Dogan Guzel; Ali Akpek; Gözde Yesiltas; Tuba Canak-Ipek; Meltem Avci-Adali
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

10.  Human serum and platelet lysate are appropriate xeno-free alternatives for clinical-grade production of human MuStem cell batches.

Authors:  Charlotte Saury; Aurélie Lardenois; Cindy Schleder; Isabelle Leroux; Blandine Lieubeau; Laurent David; Marine Charrier; Laëtitia Guével; Sabrina Viau; Bruno Delorme; Karl Rouger
Journal:  Stem Cell Res Ther       Date:  2018-05-02       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.